Analysis of dasatinib and imatinib 5-year efficacy and safety based on baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) in DASISION Meeting Abstract

   


Authors: Saglio, G.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Li, L.; Mauro, M. J.
Abstract Title: Analysis of dasatinib and imatinib 5-year efficacy and safety based on baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) in DASISION
Meeting Title: 22nd Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 102
Issue: Suppl. 2
Meeting Dates: 2017 Jun 22-25
Meeting Location: Madrid, Spain
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2017-06-26
Start Page: 436
End Page: 437
Language: English
ACCESSION: WOS:000404127003197
PROVIDER: wos
PMCID: PMC5492673
Notes: Meeting Abstract: E1060 -- Source: Wos